4D Medicine raises £3.4m to develop biomaterial for implants

Quick Summary:

The funding round was led by Oshen Holdings and backed by DSW Ventures, SFC Capital, Boundary Capital and private investors including several leading scientists and surgeons.

Preliminary testing has shown that as healing progresses, the biomaterial gradually erodes and is resorbed by normal metabolic processes as natural tissue grows back in its place.

We believe that 4Degra is a real game-changer that is enabling 4D to develop novel bioresorbable medical devices with unique properties.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Jonathan Symcox

Category: InvestingBusiness

Markets: United Kingdom

Topics: MedTech Investment

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-07-25 @ 14:53:44 (16 hours ago)

News Timezone: GMT +8:00

News Source URL: businesscloud.co.uk

Language: English

Article Length: 391 words

Reading Time: 3 minutes read

Sentences: 14 lines

Sentence Length: 28 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © BusinessCloud

News ID: 21776427

View Article Analysis

About BusinessCloud

Main Topics: InvestingBusiness

Official Website: businesscloud.co.uk

Update Frequency: 4 posts per day

Year Established: 2016

Headquarters: United Kingdom

News Last Updated: 16 hours ago

Coverage Areas: United Kingdom

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #61

Publisher Details

Frequently Asked Questions